Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Business & Decision Life Sciences (BDLS) Platinum Sponsor at This Year’s PhUSE Conference in London (12th – 15th October 2014)
  • USA - English


News provided by

Business & Decision Life Sciences

Sep 25, 2014, 08:50 ET

Share this article

Share toX

Share this article

Share toX

PhUSE Logo
PhUSE Logo

Brussels, Belgium (PRWEB UK) 25 September 2014 -- As a global CRO specialising in CDISC data solutions, BDLS is proud to be a platinum sponsor at the PhUSE 10th anniversary conference to be held in London next month.

With 10 technical CDISC presentations to be delivered across a range of conference streams, BLDS staff will be sharing our experience, insights and knowledge of the rapidly evolving data standards landscape.

“The acceptance of CDISC standards is firmly embedded throughout the industry now”

Post this

Alongside the presentations, BDLS will be conducting an interactive CDISC SDTM & ADaM workshop on behalf of PhUSE. This will be the third year that BDLS have run workshops at the conference, and pre-conference interest is high.

“The acceptance of CDISC standards is firmly embedded throughout the industry now,” commented Peter Van Reusel, BDLS’ COO, “but the rate of change means that it is a real challenge for everyone to keep up-to-date with the latest developments and releases. BDLS see this as part of our core mission and services to our clients.”

At PhUSE, more than 140 papers and posters will be presented, with BDLS delivering presentations on:

• “ADaM Conversions: The Good, The Bad and The Ugly” Carla Santillan & Jessica Minkue
• “Creating a Personal View on the Data via Using a Virtual Private Database” Sébastien Roland & Bart Van Win
• “ADaM Standards: What’s New?” Gavin Winpenny
• “How the Release of the Therapeutic Area Asthma User Guide Affects an Ongoing Submission” Nick De Donder
• “Handling non-Standardised Questionnaires” Anne Sophie Bekx
• “Your Clinical Data Standards Library Ready for Change? Adapting to TA Specific Standards” Lauren Shinaberry
• “Manage Your SAS Drug Development Environment” Bart Van Win & Sébastien Roland
• “Small Sample Bayesian Factor Analysis” Dirk Heerwegh
• “Why Don’t you Define it?” Nick De Donder & Anne-Sophie Bekx
• “FDA Guidance on Standardised Study Data for Electronic Submissions” Lauren Shinaberry

“PhUSE has become a phenomenal global success that has encouraged co-operation and commitment across the industry. This year’s theme of Data Transparency underlines the forces that will shape the next five years in pharma,” said Van Reusel. “BDLS has been a supporter of PhUSE from its inception, and I’m delighted we are platinum sponsors for the 10th anniversary event, as well as sponsoring the opening evening event.

“BDLS is actively involved CDISC data standards around the world, and we regularly present at conferences and events. The dynamic changes that are taking place in the industry means that companies need to focus on standards and their management. Our CDmation platform is helping both pharma companies and CROs save time and money in dealing with multiple changing data standards. We're excited to be able to share our experiences at this event.”

About Business & Decisions Life Sciences
Business & Decision Life Sciences is part of the Business & Decision Group, an international consulting and Systems Integration company founded in 1992 and listed on the Eurolist C exchange.

Business & Decision Life Sciences is specialized in the delivery of services and provision of solutions in the Life Sciences industry. With 20 years of experience, it supports its clients in the pharmaceutical, medical device, biotechnology, food and cosmetics industries.

Core skills include the provision of a range of expert CRO and consulting services (supporting clinical trials in the operational, data management, analytical, outcome research, and document writing area) and the implementation of technology-based, clinical applications and solutions tailored for the Life Sciences industry.

Business & Decision Life Sciences headquarters are located in Brussels, Belgium and has a strong international presence in five countries in North America and Europe. Further information is available at http://www.businessdecision-lifesciences.com/.

About CDmation
CDmation is a fully automated, CDISC compliant, clinical data standards platform and study metadata repository solution adapted to your needs. CDmation is developed in an audited and certified Quality Management System under the Software Development Life Cycle (SDLC) procedures that are required for any system that operates in a regulated environment.

The CDmation platform comprises a single user interface with 5 functional areas, enabling you to:
• Significantly increase the control over the definition of standards library
• Faster adoption of new CDISC standards
• Decrease study specification cycle times
• Ensure consistency of study definitions within projects and across compounds
• Improve the overall quality of clinical data
• Reduce delays running up to regulatory submissions
• Define study metadata for electronic data capturing (EDC) and towards your Contract Research Organization (CRO)
• Validate data and produce issue reports based on automated comparisons between data received from the CRO and your study design

Further information is available at http://www.cdmation.com

About PhUSE
PhUSE, Share – Contribute – Advance, provides the industry with the premier platform for creating and sharing ideas, tools and standards around data, statistical and reporting technologies; PhUSE is the world’s largest non-profit, volunteer-supported, community of professionals who are passionate about advancement of clinical-biometric information. Since its inception, PhUSE has expanded from its roots as a conference for European Statistical Programmers, to a global platform for the discussion of topics encompassing the work of Clinical Data Scientists and eClinical IT professionals.

The 10th PhUSE annual conference will take place October 12th to 15th at The Grange Tower Bridge Hotel in London. Visit http://www.phuse.eu/ annual-conference.aspx for further information and for registration.

Stephen Bamford, Business & Decision Life Sciences, http://www.businessdecision-lifesciences.com/, +44 7554418667, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.